Streetbeat News

Revenues

MNR

Mach Natural Resources announced its expected oil volumes for Q3 and Q4, ranging between 18.6 MBbl/d to 19.9 MBbl/d. For FY24, the company expects oil volumes to range between 19.4 MBbl/d to 20.6 MBbl/d.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 8:10 pm

INTA

IntApp has released its financial guidance for Q1 and FY25. The company expects Q1 Non-GAAP EPS to be between $0.12 and $0.14, compared to the estimated $0.12. For FY25, IntApp projects Non-GAAP EPS to be between $0.59 and $0.63, against the estimated $0.58. Additionally, FY25 total revenue is expected to be between $493 million and $497 million, compared to the estimated $494.47 million.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 8:09 pm

FATE

Fate Therapeutics (NASDAQ:FATE) reported Q2 2024 adjusted EPS of $(0.33), beating the $(0.48) estimate. Sales were $6.80M, surpassing the $1.41M estimate and marking a 628.83% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 8:09 pm

BEEP

Mobile Infrastructure (AMEX:BEEP) reported a Q2 EPS of $(0.06), a significant improvement from $(0.19) YoY, and sales of $9.27M, up from $7.21M YoY.

Portfolio Pulse from totan@benzinga.com

August 13, 2024 | 8:09 pm

SNAL

Snail (NASDAQ:SNAL) reported Q2 earnings per share of $0.06, missing the analyst estimate of $0.18 by 66.67%. Sales were $21.61M, missing the $27.80M estimate by 22.28%. Despite the misses, EPS increased by 154.55% and sales by 118.42% year-over-year.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 8:09 pm

MNR

Mach Natural Resources reported Q2 revenue of $240 million.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 8:08 pm

INLX

Intellinetics has reiterated its expectations for revenue growth on a year-over-year basis for fiscal year 2024, but has revised its expectations for Adjusted EBITDA to decline modestly compared to 2023. The company is increasing its sales and marketing investments to drive future growth.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 8:08 pm

DMRC

Digimarc (NASDAQ:DMRC) reported Q2 2024 adjusted EPS of $(0.23), beating the estimate of $(0.27). Sales were $10.379M, surpassing the $10.098M estimate and showing an 18.89% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 8:07 pm

OMIC

Singular Genomics Sys (NASDAQ:OMIC) reported Q2 2024 GAAP EPS of $(8.57), beating the $(8.95) estimate. Sales were $737K, surpassing the $400K estimate and showing a 45.94% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 8:06 pm

DRRX

Durect (NASDAQ:DRRX) reported Q2 2024 GAAP EPS of $(0.12), beating the estimate of $(0.17) by 29.41%. However, sales of $2.171M missed the $2.492M estimate by 12.87%, though it was a 4.32% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 8:06 pm